Paradigm Biopharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
24 Sep 24 | Sell€549,333 | Allianz Asset Management GmbH | Company | 3,935,875 | €0.17 | |
17 May 24 | Sell€83,367 | Allianz Asset Management GmbH | Company | 4,283,087 | €0.87 | |
30 Nov 23 | Buy€121,666 | Kzee Pty Ltd | Company | 466,000 | €0.26 | |
30 Nov 23 | Buy€266 | Helen Fisher | Individual | 1,021 | €0.26 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 13,808,269 | 3.94% |
Individual Insiders | 22,508,678 | 6.42% |
Institutions | 43,261,545 | 12.3% |
General Public | 270,785,854 | 77.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,372,860 | €2.2m | -18.5% | no data | |||
11,380,902 | €1.4m | 0% | no data | |||
10,310,378 | €1.3m | -0.42% | no data | |||
9,297,903 | €1.2m | 0% | no data | |||
7,233,311 | €896.3k | 0.47% | 0.01% | |||
3,475,835 | €430.7k | 0% | no data | |||
3,064,598 | €379.7k | 91.1% | no data | |||
3,064,597 | €379.7k | 91.1% | no data | |||
2,427,367 | €300.8k | 65.2% | no data | |||
2,337,318 | €289.6k | -41% | no data | |||
2,249,331 | €278.7k | 0% | no data | |||
1,562,000 | €193.5k | 10% | 100.0% | |||
1,441,631 | €178.6k | 0% | no data | |||
1,094,284 | €135.6k | 0% | no data | |||
1,069,830 | €132.6k | 0% | no data | |||
906,940 | €112.4k | 0% | 0.2% | |||
804,511 | €99.7k | 0% | no data | |||
279,797 | €34.7k | 1.57% | no data | |||
205,099 | €25.4k | -12.8% | no data |